Report Highlights
The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.
Report Includes
- 54 data tables and 36 additional tables
- An overview of the global markets and technologies for cell separation and characterization in solid tumors
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Overview of the main markers used for isolation, identification and purification for solid tumors, including surface cell-adhesion molecules such as CD133, CD24, hyaluronic acid (HA) receptor CD44, cytoprotective enzymes such as aldehyde dehydrogenase, ALDH, and transcription factors OCT-4, SOX-2
- Discussion of the various cell separation technique and technologies such as fluorescence-activated cell sorting (FACS), magnet-activated cell sorting (MACS), density gradient centrifugation, dielectrophoretic (DEP), aqueous two-phase system, field flow fractionation (FFF) and microfluidic platforms
- Coverage of the major products of the industry such as solid tumor kits, multi-marker solid tumor panels, reagents and microchips and micro-beads
- Comprehensive analysis of the major companies active in the market, including Abbvie, Inc., AstraZeneca, Beckman Coulter, Daiichi Sankyo and Pfizer, Inc.
Report Scope
This report consists of the overall analysis of the market landscape. It provides in-depth analysis on market size, growth opportunity in market and product types. The report will serve as a source for 360-degree analysis of the market, thoroughly integrating different models. The solid tumor products in clinical trials and current products available on the market have been studied thoroughly. The report also consists of a detailed overview of all the cell separation technologies and techniques. In addition, the cancer diagnostics market chapter has been provided in detail to give the overall insights in the development of cancer diagnosis technologies. R&D budget of organizations and companies in oncology research have been analyzed in detail. Different approaches have been worked on to derive the market value and market growth rate. Facts and data related to the market from different geographic areas provide a better regional outlook in the report. In the report, country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. This report will help the companies and organizations have an all-around analysis of the cell separation and characterization in the solid tumor market and the most preferred markets regionally.
Analyst Credentials
ANUJ PATHAK has written and researched the global medical device market, surgical instruments and biotechnology market. Skilled in information technology and computer management, he has an undergraduate business degree and an MBA degree.
Related Reports
Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
The global market for CAR T-cell therapy is expected to grow from $4.6 billion in 2024 and projected to reach $25.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 40.2% from 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
Recent Reports
Organ-on-a-Chip: Global Markets
The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.
Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Current Research and Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
The global market for CAR T-cell therapy is expected to grow from $4.6 billion in 2024 and projected to reach $25.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 40.2% from 2024 to 2029.
Therapeutics for Women's Health: Technologies and Global Markets
The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.
2024 Protein Synthesis Research Review
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.
Top Trending Reports
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More